AVROXA
Technologiepark-Zwijnaarde 82
9052 Gent
BE
AVROXA
Foundation date
10/01/2018
Sector
#Medical TechnologySubsector
- #Medtech - Biomaterials
- #Medtech - Coatings
- #Medtech - Delivery devices
- #Medtech - Diagnostic devices
- #Medtech - Non-active implantable devices
- #Medtech - Regenerative Medicine
AVROXA is a research and manufacturing company committed to the development of innovative solutions based on our versatile proprietary polymer platform technology of poly(2-oxazoline)s (abbreviated as POZ, PAOx,POX). We develop a vast range of high-quality, well-defined, ultra-pure poly(2-oxazoline)s under the brandname ULTROXA(R) for applications in therapeutics, drug delivery, biomaterials and diagnostics.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
20 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Wednesday November 20th 2024
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator